UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of report (Date of earliest event reported):
(Exact Name of Registrant as Specified in Charter)
|
|
| ||
(State or Other Jurisdiction of Incorporation) |
(Commission File Number) |
(I.R.S. Employer Identification No.) |
(Address of Principal Executive Offices, and Zip Code)
Registrant’s Telephone Number, Including Area Code
Not Applicable
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
|
Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
|
Pre-commencement communication pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
|
Pre-commencement communication pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
Title of each class |
Trading Symbol(s) |
Name of each exchange on which registered | ||
|
|
|
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 8.01 | Other Events. |
On December 18, 2019, McKesson Corporation (“Company”) issued a press release that reaffirmed the Company’s earnings guidance. A copy of the Company’s press release is attached as Exhibit 99.1.
Item 9.01 | Financial Statements and Exhibits. |
(d) Exhibits.
Exhibit |
Description | |||
99.1 |
Press release issued by the Company dated December 18, 2019. | |||
104 |
Cover Page Interactive Data File - the cover page iXBRL tags are embedded within the Inline XBRL document |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date: December 18, 2019
McKesson Corporation | ||
By: |
/s/ Britt J. Vitalone | |
Britt J. Vitalone | ||
Executive Vice President and Chief Financial Officer |
Exhibit 99.1
McKESSON REAFFIRMS FISCAL 2020 GUIDANCE
IRVING, Texas, December 18, 2019 McKesson Corporation (NYSE:MCK) today reaffirmed its Adjusted Earnings per diluted share guidance of $14.00 to $14.60 for the fiscal year ending March 31, 2020.
McKesson is hosting a sell-side analyst meeting today at its corporate headquarters in Irving, Texas. A live audio webcast of the meeting will be available beginning at 12:30 PM ET. A link to the live audio webcast and the presentation materials will be available on McKessons Investor Relations website at http://investor.mckesson.com. An archive of the webcast and presentation materials will also be available on the website shortly after the meeting.
Cautionary Statements
The guidance contained in this press release constitutes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, that involve risks and uncertainties that could cause actual results to differ materially from those in those statements. The reader should not place undue reliance on forward-looking statements, which speak only as of the date they are first made. Except to the extent required by law, the Company undertakes no obligation to publicly update forward-looking statements. It is not possible to identify all such risks and uncertainties. We encourage investors to read the important risk factors described in the Risk Factors section of the Companys Form 10-K and Form 10-Q reports filed with the Securities and Exchange Commission. These risk factors include, but are not limited to: changes in the healthcare industry and regulatory environment; fluctuations in foreign currency exchange rates; the impact of the Change Healthcare joint venture on the companys results of operations; the companys ability to manage and complete divestitures and distributions; material adverse resolution of pending legal proceedings, including those related to the distribution of controlled substances; cyberattack, natural disaster, or malfunction of sophisticated internal computer systems to perform as designed; and the potential inadequacy of insurance to cover property loss or liability claims.
About McKesson Corporation
McKesson Corporation is a global leader in healthcare supply chain management solutions, retail pharmacy, healthcare technology, community oncology and specialty care. McKesson partners with life sciences companies, manufacturers, providers, pharmacies, governments and other healthcare organizations to help provide the right medicines, medical products and healthcare services to the right patients at the right time, safely and cost-effectively. United by our ICARE shared principles, our employees work every day to innovate and deliver opportunities to improve patient care in every setting one product, one partner, one patient at a time. McKesson has been named a Most Admired Company in the healthcare wholesaler category by FORTUNE, a Best Place to Work by the Human Rights Campaign Foundation, and a top military-friendly company by Military Friendly. For more information, visit www.mckesson.com.
###
Contact:
Investors and Financial Media:
Holly Weiss
972-969-9174
Holly.Weiss@McKesson.com
Document and Entity Information |
Dec. 18, 2019 |
---|---|
Cover [Abstract] | |
Entity Registrant Name | MCKESSON CORP |
Amendment Flag | false |
Entity Central Index Key | 0000927653 |
Document Type | 8-K |
Document Period End Date | Dec. 18, 2019 |
Entity Incorporation State Country Code | DE |
Entity File Number | 1-13252 |
Entity Tax Identification Number | 94-3207296 |
Entity Address, Address Line One | 6555 State Hwy 161 |
Entity Address, City or Town | Irving |
Entity Address, State or Province | TX |
Entity Address, Postal Zip Code | 75039 |
City Area Code | (972) |
Local Phone Number | 446-4800 |
Written Communications | false |
Soliciting Material | false |
Pre Commencement Tender Offer | false |
Pre Commencement Issuer Tender Offer | false |
Security 12b Title | Common stock, $0.01 par value |
Trading Symbol | MCK |
Security Exchange Name | NYSE |
Entity Emerging Growth Company | false |
F%S$&,[Q(.O \!HS-Q^!UH$F8J:-]CQ&&>!]/@Z*R?:>CGD+IN\ASQ
MIK^NQ BU!5YV L^CH60-R4(*T\N2@KCM1AYL7J]OJS):&;81#4)$'V["7=1+
MN?)#$^&S Q4 !$ !D.#0T
M-S0Q9&5X.3DQ+FAT;_+=*=N$&^?Z5Z7UEZ?I:YNS&'7[47QXY/8(!T$=F>&/1?CU@GK
MU0!]?]G"E1.&V?1F\L*HZ#5T+P#870>)L$*@S@A=T%V,4R@P4JZ-9ZGB #O3<49?EL?O!_]!&^Q6P
M"LE7PMVHM7,2_E38P^!B?'U6:38:_UPOUKW^[;@_^K^[.-%\[TX,.O/9_?A/
M=OLWF?+/&@8_7=2.VD>'10+:[FW_LW>
M!Z#J :A_ERQ!3?#*5H'JN;OXA)?A/UW_ %!+ P04 " "&19)//)6]_&8#
M B# $ &UC:RTR,#$Y,3(Q."YX